Tevogen Bio Statistics Share Statistics Tevogen Bio has 196.71M
shares outstanding. The number of shares has increased by 12.37%
in one year.
Shares Outstanding 196.71M Shares Change (YoY) 12.37% Shares Change (QoQ) 6.65% Owned by Institutions (%) 2.82% Shares Floating 44.19M Failed to Deliver (FTD) Shares 11,361 FTD / Avg. Volume 1.35%
Short Selling Information The latest short interest is 2.59M, so 1.32% of the outstanding
shares have been sold short.
Short Interest 2.59M Short % of Shares Out 1.32% Short % of Float 4.18% Short Ratio (days to cover) 4.35
Valuation Ratios The PE ratio is -11.01 and the forward
PE ratio is -3.25.
Tevogen Bio's PEG ratio is
0.
PE Ratio -11.01 Forward PE -3.25 PS Ratio 0 Forward PS n/a PB Ratio -22.64 P/FCF Ratio -12.59 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tevogen Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.26,
with a Debt / Equity ratio of -0.43.
Current Ratio 0.26 Quick Ratio 0.26 Debt / Equity -0.43 Debt / EBITDA -0.22 Debt / FCF -0.24 Interest Coverage -291.05
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-762.63K Employee Count 18 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 140.14% in the
last 52 weeks. The beta is -0.81, so Tevogen Bio's
price volatility has been lower than the market average.
Beta -0.81 52-Week Price Change 140.14% 50-Day Moving Average 0.9 200-Day Moving Average 1.13 Relative Strength Index (RSI) 26.65 Average Volume (20 Days) 841,612
Income Statement
Revenue n/a Gross Profit -403.58K Operating Income -53.56M Net Income -13.73M EBITDA -13.14M EBIT -13.54M Earnings Per Share (EPS) -0.09
Full Income Statement Balance Sheet The company has 1.28M in cash and 2.89M in
debt, giving a net cash position of -1.6M.
Cash & Cash Equivalents 1.28M Total Debt 2.89M Net Cash -1.6M Retained Earnings -113.39M Total Assets 4.27M Working Capital -6.02M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12M
and capital expenditures 0, giving a free cash flow of -12M.
Operating Cash Flow -12M Capital Expenditures n/a Free Cash Flow -12M FCF Per Share -0.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
